Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

11 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Immune checkpoint inhibitors therapy for solid organ malignancies after allogeneic hematopoietic stem cell transplantation: a retrospective study from the EBMT Transplant Complications Working Party.
Brijs J, Peczynski C, Boreland W, Cuoghi A, Maertens J, Mohty M, Kröger N, Nakov P, Broers AEC, Eder M, Herrera Arroyo C, Kaufmann M, Ram R, Schaap NPM, Graham C, Mussetti A, Penack O, Moiseev I, Peric Z, Schoemans H. Brijs J, et al. Among authors: boreland w. Bone Marrow Transplant. 2024 Dec 13. doi: 10.1038/s41409-024-02497-8. Online ahead of print. Bone Marrow Transplant. 2024. PMID: 39668190 No abstract available.
Graft-versus-host disease after anti-CD19 chimeric antigen receptor T-cell therapy following allogeneic hematopoietic cell transplantation: a transplant complications and paediatric diseases working parties joint EBMT study.
Ortí G, Peczynski C, Boreland W, O'Reilly M, von Bonin M, Balduzzi A, Besley C, Kalwak K, Ryhänen S, Güngör T, Wynn RF, Bader P, Mielke S, Blaise D, Amrolia P, Yakoub-Agha I, Calkoen F, Schubert ML, Potter V, Pichler H, Kröger N, Kwon M, Sengeloev H, Torrent A, Chalandon Y, van Gorkom G, Koenecke C, Graham C, Schoemans H, Moiseev I, Penack O, Peric Z. Ortí G, et al. Among authors: boreland w. Leukemia. 2024 Nov 19. doi: 10.1038/s41375-024-02467-5. Online ahead of print. Leukemia. 2024. PMID: 39562721
Correction: ECP versus ruxolitinib in steroid-refractory chronic GVHD - a retrospective study by the EBMT transplant complications working party.
Penack O, Peczynski C, Boreland W, Lemaitre J, Reinhardt HC, Afanasyeva K, Avenoso D, Holderried TAW, Kornblit BT, Gavriilaki E, Martinez C, Chiusolo P, Mico MC, Daguenet E, Wichert S, Ozdogu H, Piekarska A, Kinsella F, Basak GW, Schoemans H, Koenecke C, Moiseev I, Peric Z. Penack O, et al. Among authors: boreland w. Bone Marrow Transplant. 2024 Oct 18. doi: 10.1038/s41409-024-02435-8. Online ahead of print. Bone Marrow Transplant. 2024. PMID: 39424959 No abstract available.
How risky is a second allogeneic stem cell transplantation?
Penack O, Abouqateb M, Peczynski C, Boreland W, Kröger N, Zeiser R, Ciceri F, Schroeder T, Dreger P, Passweg J, Schetelig J, Stelljes M, Blau IW, Franke GN, Riesner K, Schoemans H, Moiseev I, Peric Z. Penack O, et al. Among authors: boreland w. Leukemia. 2024 Aug;38(8):1799-1807. doi: 10.1038/s41375-024-02318-3. Epub 2024 Jun 25. Leukemia. 2024. PMID: 38918561 Free PMC article.
Patient engagement in hematopoietic stem cell transplantation and cell therapy: a survey by the EBMT patient engagement task force & transplantation complications working party.
Schoemans H, Burns LJ, Liptrott SJ, Murray J, Kenyon M, Barata A, Bolaños N, Scholl I, Hamilton B, Phelan R, Buchbinder D, Penack O, Moiseev I, Boreland W, Peczynski C, De Geest S, Sureda A, Snowden JA, Shaw B, Peric Z, Kroeger N. Schoemans H, et al. Among authors: boreland w. Bone Marrow Transplant. 2024 Sep;59(9):1286-1294. doi: 10.1038/s41409-024-02290-7. Epub 2024 Jun 18. Bone Marrow Transplant. 2024. PMID: 38890544
ATG or post-transplant cyclophosphamide to prevent GVHD in matched unrelated stem cell transplantation?
Penack O, Abouqateb M, Peczynski C, Boreland W, Kröger N, Stelljes M, Gedde-Dahl T, Blau IW, Schroeder T, Salmenniemi U, Kulagin A, Peffault de Latour R, Mielke S, Zeiser R, Moiseev I, Schoemans H, Koenecke C, Peric Z. Penack O, et al. Among authors: boreland w. Leukemia. 2024 May;38(5):1156-1163. doi: 10.1038/s41375-024-02225-7. Epub 2024 Mar 27. Leukemia. 2024. PMID: 38538862 Free PMC article.
PTCy versus ATG as graft-versus-host disease prophylaxis in mismatched unrelated stem cell transplantation.
Penack O, Abouqateb M, Peczynski C, Boreland W, Gülbas Z, Gedde-Dahl T, Castilla-Llorente C, Kröger N, Eder M, Rambaldi A, Bonifazi F, Blau IW, Stelljes M, Dreger P, Moiseev I, Schoemans H, Koenecke C, Peric Z. Penack O, et al. Among authors: boreland w. Blood Cancer J. 2024 Mar 15;14(1):45. doi: 10.1038/s41408-024-01032-8. Blood Cancer J. 2024. PMID: 38485723 Free PMC article.
ECP versus ruxolitinib in steroid-refractory chronic GVHD - a retrospective study by the EBMT transplant complications working party.
Penack O, Peczynski C, Boreland W, Lemaitre J, Reinhardt HC, Afanasyeva K, Avenoso D, Holderried TAW, Kornblit BT, Gavriilaki E, Martinez C, Chiusolo P, Mico MC, Daguenet E, Wichert S, Ozdogu H, Piekarska A, Kinsella F, Basak GW, Schoemans H, Koenecke C, Moiseev I, Peric Z. Penack O, et al. Among authors: boreland w. Bone Marrow Transplant. 2024 Mar;59(3):380-386. doi: 10.1038/s41409-023-02174-2. Epub 2024 Jan 6. Bone Marrow Transplant. 2024. PMID: 38184740 Free PMC article.
ECP versus ruxolitinib in steroid-refractory acute GVHD - a retrospective study by the EBMT transplant complications working party.
Penack O, Peczynski C, Boreland W, Lemaitre J, Afanasyeva K, Kornblit B, Jurado M, Martinez C, Natale A, Pérez-Simón JA, Brunello L, Avenoso D, Klein S, Ozkurt ZN, Herrera C, Wichert S, Chiusolo P, Gavriilaki E, Basak GW, Schoemans H, Koenecke C, Moiseev I, Peric Z. Penack O, et al. Among authors: boreland w. Front Immunol. 2023 Dec 11;14:1283034. doi: 10.3389/fimmu.2023.1283034. eCollection 2023. Front Immunol. 2023. PMID: 38149251 Free PMC article.
11 results